Prestige Consumer Healthcare (PBH) Free Cash Flow Growth (5y) (2015 - 2025)
Prestige Consumer Healthcare (PBH) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.59% |
| Sep 30, 2025 | 5.16% |
| Jun 30, 2025 | 1.49% |
| Mar 31, 2025 | 2.89% |
| Dec 31, 2024 | 3.01% |
| Sep 30, 2024 | 7.89% |
| Jun 30, 2024 | 1.08% |
| Mar 31, 2024 | 6.06% |
| Dec 31, 2023 | 10.98% |
| Sep 30, 2023 | 10.19% |
| Jun 30, 2023 | -2.68% |
| Mar 31, 2023 | 1.82% |
| Dec 31, 2022 | 4.69% |
| Sep 30, 2022 | 1.12% |
| Jun 30, 2022 | 2.10% |
| Mar 31, 2022 | 56.04% |
| Dec 31, 2021 | 10.14% |
| Sep 30, 2021 | 3.47% |
| Jun 30, 2021 | 6.11% |
| Mar 31, 2021 | 6.89% |